CONTACT USCall toll free: 1-800-411-1222
Se habla español.
Or e-mail: email@example.com
SEARCH THE STUDIESYou can search the collection of research studies being conducted at the NIH Clinical Center at Search the Studies. In addition, clinicaltrials.gov provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.
Idiopathic Membranous Nephropathy Study
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is conducting a pilot intervention study for patients diagnosed with idiopathic membranous nephropathy. The purpose of this study is to evaluate the safety and effectiveness of Rituximab plus Cyclosporine in the treatment of membranous nephropathy. There is no cost for study-related medications or tests received. The study will be conducted at the NIH Clinical Center in Bethesda, Maryland.
To participate in this study patient must:
- Be an adult at least 18 years of age
- Have a diagnosis of idiopathic membranous nephropathy
- Have had a renal biopsy within the past 24 months that shows typical changes of membranous nephropathy
Patients may not be eligible if they have:
- Received previous treatment with Rituximab
- Been treated with Cyclosporine for more than 6 months
For more information, please call toll free:
Se habla español
Department of Health and Human Services
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases
Print the Flyer
NOTE: PDF documents require the free Adobe Reader.
This page last updated on 09/07/2017